Only with quality data from all countries can we respond to the growing threat of AMR.
Forging the path to effective care
With our novel, hand-held platform, we provide fast, affordable and data-driven diagnostics to close the gap between diagnostic needs and diagnostic access.
For effective treatment and less days of suffering - in every corner of the world.
“If we don’t act now, by 2050 one person will die every three seconds due to Antimicrobial Resistance.”
What is Antimicrobial Resistance?
Antimicrobial resistance (AMR) is defined as the ability of microorganisms (like bacteria, fungi or viruses) to resist the effect of antimicrobial agents such as antibiotics, antifungal or antiviral medicines. Currently, AMR is directly linked to 1.3 million deaths world wide, a number expected to increase to 10 million by 2050.
A lack of effective and quick diagnostic solutions have promoted self-medication or empirical antimicrobial treatments by clinicians and GPs as a prompt and easy solution to infections, ultimately accelerating the rise of AMR.
If AMR is not curbed, it will lead to rising infection rates and harder-to-treat infections that require more expensive treatment or longer hospitalisation times because of ineffective antimicrobials.
”To truly understand the extent of the global threat and mount an effective public health response to AMR, we must scale up microbiology testing and provide quality-assured data across all countries, not just wealthier ones.Dr Tedros Adhanom GhebreyesusWHO Director-General